Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of DTaP-IPV-HB-PRP~T Combined Vaccine in Latin American Infants
NCT00313911Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2006
- Primary completion
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of hexaxim in diphtheria, Tetanus, pertussis and 3 more (2 arms), sponsored by Sanofi. Primary endpoint: Number of Participants With High Fever Observed After Vaccination. Started Jul 2006; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00313911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313911.